NDC 78206-147

Ontruzant

Trastuzumab

Ontruzant is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Trastuzumab.

• Product ID: 78206-147_ca182adf-2c29-47da-9e4e-e86e4b25cc49
• NDC: 78206-147
• Product Type: Human Prescription Drug
• Proprietary Name: Ontruzant
• Generic Name: Trastuzumab
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-06-01
• Marketing Category: BLA /
• Application Number: BLA761100
• Labeler Name: Organon LLC
• Substance Name: TRASTUZUMAB
• Active Ingredient Strength: 150 mg/1
• Pharm Classes: HER2/neu Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 78206-147-01

1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99)

• Marketing Start Date: 2021-06-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Ontruzant" or generic name "Trastuzumab"

NDC	Brand Name	Generic Name
0006-5033	Ontruzant	trastuzumab
0006-5034	Ontruzant	Ontruzant
50242-132	Herceptin	Trastuzumab
50242-134	Herceptin	Trastuzumab
50242-333	Herceptin	Trastuzumab
63459-303	HERZUMA	TRASTUZUMAB
63459-305	HERZUMA	TRASTUZUMAB
67457-845	OGIVRI	trastuzumab
67457-847	OGIVRI	trastuzumab
67457-991	OGIVRI	trastuzumab
0069-0305	Trazimera-qyyp	trastuzumab